Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Am Vanguard AVD Stock Down 145 Support Test at 257 20260518 Kiplinger GDP Outlook Goldilocks Economy Neither Hot nor Cold What It Means for Investors Dycom DY Stock Slides 319 Support at 41476 20260515 Stoke Therapeutics STOK Stock Down 265 Support Test at 2932 20260514 Is Clearmind CMND Still a Buy After 368 Rally 20260520 TGL Q3 2024 Earnings Narrowed Loss Exceeds Expectations Shares Rally Why Imax Corporation IMAX Just Surged 341 Key Levels Ahead 20260520 ImageneBio IMA Q1 2026 Results Fall Short EPS 095 Revenue NA Teen GLP1 Purchases Raise Concerns Over App Store Accountability Frameworks Loop Capital Initiates American Express Coverage with Buy Rating Names Stock Top Pick Morrisons Announces Plans to Close Approximately 100 Stores Amid Government Cost Pressures JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India MD Discusses Business Outlook AI Infrastructure and Energy Basket May Outperform Nvidia Market Data Suggests Google Pixel Launch Reignites Privacy Debate Over AI Assistant Data Collection CMBT Q1 2026 Earnings Massive EPS Surprise of 432 Driven by Strong Operational Performance ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick ASX Q1 2026 Earnings EPS Surpasses Estimates by 9 Stock Rises SUNC Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds STRL Q1 2026 Earnings Stellar EPS Surprise of 506 Despite Negative Market Reaction Worthington Enterprises WOR Shows Modest Gains Testing Key Resistance Levels Structure Therapeutics GPCR Edges Higher on Modest Gains Testing Key Resistance Levels CrossAmerica Partners LP CAPL Holds Steady A Narrow Trading Range Amid Sector Stability Gabelli MultiMedia Trust GGT Holds Steady Near Support as Consolidation Continues SXT Q1 2026 Earnings Strong EPS Beat Driven by Margin Improvement Medline Inc MDLN Q1 2026 Earnings EPS Surpasses Estimates by 949 Amidst Limited Revenue Disclosure ORI Q1 2026 Earnings EPS Misses Estimates as Operating Environment Challenges Persist QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally DMLP Q4 2024 Earnings EPS of 024 Reported Amid Commodity Price Fluctuations Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues